THE EFFECT OF A NON-ALKYLATED ANABOLIC STEROID, QUINBOLONE, ON LIVER FUNCTION AND ANTICOAGULANT REQUIREMENTS.
D000410:Alanine Transaminase; D045930:Anabolic Agents; D000730:Androstadienes; D000925:Anticoagulants; D001219:Aspartate Aminotransferases; D035843:Biomedical Research; D001769:Blood; D001777:Blood Coagulation; D004358:Drug Therapy; D005853:Geriatrics; D006801:Humans; D008099:Liver / Q000502:physiology*; D013256:Steroids; D013448:Sulfobromophthalein; D014859:Warfarin
D045930:Anabolic Agents; D000730:Androstadienes; D000925:Anticoagulants; D013256:Steroids; D013448:Sulfobromophthalein; D014859:Warfarin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C005620:quinbolone
ALANINE AMINOTRANSFERASE; ANABOLIC STEROIDS; ASPARTATE AMINOTRANSFERASE; BLOOD; BLOOD COAGULATION; CLINICAL RESEARCH; DRUG THERAPY; GERIATRICS; LIVER FUNCTION; SULFOBROMOPHTHALEIN; WARFARIN